Non-opioid Pain Patches-Global Market Status and Trend Report 2013-2023
Report Summary
Non-opioid Pain Patches-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-opioid Pain Patches industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Non-opioid Pain Patches 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Non-opioid Pain Patches worldwide, with company and product introduction, position in the Non-opioid Pain Patches market
Market status and development trend of Non-opioid Pain Patches by types and applications
Cost and profit status of Non-opioid Pain Patches, and marketing status
Market growth drivers and challenges
The report segments the global Non-opioid Pain Patches market as:
Global Non-opioid Pain Patches Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Non-opioid Pain Patches Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Other
Global Non-opioid Pain Patches Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Global Non-opioid Pain Patches Market: Manufacturers Segment Analysis (Company and Product introduction, Non-opioid Pain Patches Sales Volume, Revenue, Price and Gross Margin):
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Non-opioid Pain Patches-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-opioid Pain Patches industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Non-opioid Pain Patches 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Non-opioid Pain Patches worldwide, with company and product introduction, position in the Non-opioid Pain Patches market
Market status and development trend of Non-opioid Pain Patches by types and applications
Cost and profit status of Non-opioid Pain Patches, and marketing status
Market growth drivers and challenges
The report segments the global Non-opioid Pain Patches market as:
Global Non-opioid Pain Patches Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Non-opioid Pain Patches Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Other
Global Non-opioid Pain Patches Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Global Non-opioid Pain Patches Market: Manufacturers Segment Analysis (Company and Product introduction, Non-opioid Pain Patches Sales Volume, Revenue, Price and Gross Margin):
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NON-OPIOID PAIN PATCHES
1.1 Definition of Non-opioid Pain Patches in This Report
1.2 Commercial Types of Non-opioid Pain Patches
1.2.1 Lidocaine Patch
1.2.2 Diclofenac Patch
1.2.3 Methyl Salicylate Patch
1.2.4 Capsaicin Patch
1.2.5 Ketoprofen Patch
1.2.6 Other
1.3 Downstream Application of Non-opioid Pain Patches
1.3.1 Hospital Pharmacies
1.3.2 Independent Pharmacies & Drug Stores
1.3.3 Online Pharmacies
1.4 Development History of Non-opioid Pain Patches
1.5 Market Status and Trend of Non-opioid Pain Patches 2013-2023
1.5.1 Global Non-opioid Pain Patches Market Status and Trend 2013-2023
1.5.2 Regional Non-opioid Pain Patches Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Non-opioid Pain Patches 2013-2017
2.2 Production Market of Non-opioid Pain Patches by Regions
2.2.1 Production Volume of Non-opioid Pain Patches by Regions
2.2.2 Production Value of Non-opioid Pain Patches by Regions
2.3 Demand Market of Non-opioid Pain Patches by Regions
2.4 Production and Demand Status of Non-opioid Pain Patches by Regions
2.4.1 Production and Demand Status of Non-opioid Pain Patches by Regions 2013-2017
2.4.2 Import and Export Status of Non-opioid Pain Patches by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Non-opioid Pain Patches by Types
3.2 Production Value of Non-opioid Pain Patches by Types
3.3 Market Forecast of Non-opioid Pain Patches by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Non-opioid Pain Patches by Downstream Industry
4.2 Market Forecast of Non-opioid Pain Patches by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NON-OPIOID PAIN PATCHES
5.1 Global Economy Situation and Trend Overview
5.2 Non-opioid Pain Patches Downstream Industry Situation and Trend Overview
CHAPTER 6 NON-OPIOID PAIN PATCHES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Non-opioid Pain Patches by Major Manufacturers
6.2 Production Value of Non-opioid Pain Patches by Major Manufacturers
6.3 Basic Information of Non-opioid Pain Patches by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Non-opioid Pain Patches Major Manufacturer
6.3.2 Employees and Revenue Level of Non-opioid Pain Patches Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NON-OPIOID PAIN PATCHES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Non-opioid Pain Patches Product
7.1.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Pfizer
7.2 GlaxoSmithKline
7.2.1 Company profile
7.2.2 Representative Non-opioid Pain Patches Product
7.2.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.3 Johnson & Johnson
7.3.1 Company profile
7.3.2 Representative Non-opioid Pain Patches Product
7.3.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.4 Novartis AG
7.4.1 Company profile
7.4.2 Representative Non-opioid Pain Patches Product
7.4.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Novartis AG
7.5 Mylan N.V.
7.5.1 Company profile
7.5.2 Representative Non-opioid Pain Patches Product
7.5.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.6 Teva Pharmaceutical Industries
7.6.1 Company profile
7.6.2 Representative Non-opioid Pain Patches Product
7.6.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.7 Hisamitsu Pharmaceutical
7.7.1 Company profile
7.7.2 Representative Non-opioid Pain Patches Product
7.7.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.8 TEH SENG Pharmaceutical
7.8.1 Company profile
7.8.2 Representative Non-opioid Pain Patches Product
7.8.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of TEH SENG Pharmaceutical
7.9 Teikoku Seiyaku
7.9.1 Company profile
7.9.2 Representative Non-opioid Pain Patches Product
7.9.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Teikoku Seiyaku
7.10 IBSA Institut Biochimque SA
7.10.1 Company profile
7.10.2 Representative Non-opioid Pain Patches Product
7.10.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of IBSA Institut Biochimque SA
7.11 Acorda Therapeutics
7.11.1 Company profile
7.11.2 Representative Non-opioid Pain Patches Product
7.11.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Acorda Therapeutics
7.12 Allergan PLC
7.12.1 Company profile
7.12.2 Representative Non-opioid Pain Patches Product
7.12.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Allergan PLC
7.13 Endo International
7.13.1 Company profile
7.13.2 Representative Non-opioid Pain Patches Product
7.13.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Endo International
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NON-OPIOID PAIN PATCHES
8.1 Industry Chain of Non-opioid Pain Patches
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NON-OPIOID PAIN PATCHES
9.1 Cost Structure Analysis of Non-opioid Pain Patches
9.2 Raw Materials Cost Analysis of Non-opioid Pain Patches
9.3 Labor Cost Analysis of Non-opioid Pain Patches
9.4 Manufacturing Expenses Analysis of Non-opioid Pain Patches
CHAPTER 10 MARKETING STATUS ANALYSIS OF NON-OPIOID PAIN PATCHES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Non-opioid Pain Patches in This Report
1.2 Commercial Types of Non-opioid Pain Patches
1.2.1 Lidocaine Patch
1.2.2 Diclofenac Patch
1.2.3 Methyl Salicylate Patch
1.2.4 Capsaicin Patch
1.2.5 Ketoprofen Patch
1.2.6 Other
1.3 Downstream Application of Non-opioid Pain Patches
1.3.1 Hospital Pharmacies
1.3.2 Independent Pharmacies & Drug Stores
1.3.3 Online Pharmacies
1.4 Development History of Non-opioid Pain Patches
1.5 Market Status and Trend of Non-opioid Pain Patches 2013-2023
1.5.1 Global Non-opioid Pain Patches Market Status and Trend 2013-2023
1.5.2 Regional Non-opioid Pain Patches Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Non-opioid Pain Patches 2013-2017
2.2 Production Market of Non-opioid Pain Patches by Regions
2.2.1 Production Volume of Non-opioid Pain Patches by Regions
2.2.2 Production Value of Non-opioid Pain Patches by Regions
2.3 Demand Market of Non-opioid Pain Patches by Regions
2.4 Production and Demand Status of Non-opioid Pain Patches by Regions
2.4.1 Production and Demand Status of Non-opioid Pain Patches by Regions 2013-2017
2.4.2 Import and Export Status of Non-opioid Pain Patches by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Non-opioid Pain Patches by Types
3.2 Production Value of Non-opioid Pain Patches by Types
3.3 Market Forecast of Non-opioid Pain Patches by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Non-opioid Pain Patches by Downstream Industry
4.2 Market Forecast of Non-opioid Pain Patches by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NON-OPIOID PAIN PATCHES
5.1 Global Economy Situation and Trend Overview
5.2 Non-opioid Pain Patches Downstream Industry Situation and Trend Overview
CHAPTER 6 NON-OPIOID PAIN PATCHES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Non-opioid Pain Patches by Major Manufacturers
6.2 Production Value of Non-opioid Pain Patches by Major Manufacturers
6.3 Basic Information of Non-opioid Pain Patches by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Non-opioid Pain Patches Major Manufacturer
6.3.2 Employees and Revenue Level of Non-opioid Pain Patches Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NON-OPIOID PAIN PATCHES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer
7.1.1 Company profile
7.1.2 Representative Non-opioid Pain Patches Product
7.1.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Pfizer
7.2 GlaxoSmithKline
7.2.1 Company profile
7.2.2 Representative Non-opioid Pain Patches Product
7.2.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.3 Johnson & Johnson
7.3.1 Company profile
7.3.2 Representative Non-opioid Pain Patches Product
7.3.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.4 Novartis AG
7.4.1 Company profile
7.4.2 Representative Non-opioid Pain Patches Product
7.4.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Novartis AG
7.5 Mylan N.V.
7.5.1 Company profile
7.5.2 Representative Non-opioid Pain Patches Product
7.5.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.6 Teva Pharmaceutical Industries
7.6.1 Company profile
7.6.2 Representative Non-opioid Pain Patches Product
7.6.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.7 Hisamitsu Pharmaceutical
7.7.1 Company profile
7.7.2 Representative Non-opioid Pain Patches Product
7.7.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Hisamitsu Pharmaceutical
7.8 TEH SENG Pharmaceutical
7.8.1 Company profile
7.8.2 Representative Non-opioid Pain Patches Product
7.8.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of TEH SENG Pharmaceutical
7.9 Teikoku Seiyaku
7.9.1 Company profile
7.9.2 Representative Non-opioid Pain Patches Product
7.9.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Teikoku Seiyaku
7.10 IBSA Institut Biochimque SA
7.10.1 Company profile
7.10.2 Representative Non-opioid Pain Patches Product
7.10.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of IBSA Institut Biochimque SA
7.11 Acorda Therapeutics
7.11.1 Company profile
7.11.2 Representative Non-opioid Pain Patches Product
7.11.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Acorda Therapeutics
7.12 Allergan PLC
7.12.1 Company profile
7.12.2 Representative Non-opioid Pain Patches Product
7.12.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Allergan PLC
7.13 Endo International
7.13.1 Company profile
7.13.2 Representative Non-opioid Pain Patches Product
7.13.3 Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of Endo International
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NON-OPIOID PAIN PATCHES
8.1 Industry Chain of Non-opioid Pain Patches
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NON-OPIOID PAIN PATCHES
9.1 Cost Structure Analysis of Non-opioid Pain Patches
9.2 Raw Materials Cost Analysis of Non-opioid Pain Patches
9.3 Labor Cost Analysis of Non-opioid Pain Patches
9.4 Manufacturing Expenses Analysis of Non-opioid Pain Patches
CHAPTER 10 MARKETING STATUS ANALYSIS OF NON-OPIOID PAIN PATCHES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
